Biotechnology in Israel

University Of Sevilla

1 to 10 staff

Biobee Sde Eliyahu Ltd

BioBee Sde Eliyahu Ltd. is a unique company which produces beneficial insects and mites for agricultural purposes. These organisms include natural enemies for integrated biological pest control and bumblebees for natural pollination. Biological Control - BioBee's products serve both conventional and organic growers. They constitute an indispensable component in Integrated Pest Management (IPM), which aims at reducing the use of harsh chemical pesticides. IPM is at the forefront of modern agriculture and is an effective method to reduce chemical residues, and prevent the development of pesticide resistance. Biobee's products are implemented in Israel and abroad in thousands of hectares of greenhouses and open fields. Natural Pollination – BioBee produces Bombus terrestris for pollination of numerous agricultural crops including greenhouse vegetables (e.g. tomato, sweet pepper, eggplant, squash, strawberry, etc.) and open field plantations such as apple, pear, cherry, blueberry and others.

201 to 500 staff

Danyel Biotech

Danyel Biotech is a healthcare company, part of the Gamida for Life Group. This group is an interdisciplinary privately-owned group, designed to provide a focused and comprehensive service of supply and support to the Israeli scientific research community specializing in biotechnology and molecular biology, and to offer a point of contact between academic and medical research groups and their colleagues in the industrial sector.

51 to 200 staff

Seach Medical Group

Seach is an Israeli based medical Cannabis group focused on growing, developing and producing top-grade medical Cannabis products and technologies. In 2002, Seach was the first group to apply for an Israeli license to grow Cannabis for medical purposes. In 2005 Seach was granted the first commercial growing license from the Israeli Minister of Health ("MOH") to serve patients in Israel. Seach started as a small family-based operation, supplying Medical Cannabis to Israeli MOH and directly to patients. Seach, is an outgrowth of a 60 year old, large Israeli floriculture farm. The four founders of Seach have over 50 years of experience in agriculture industry and over 10 years of experience in Medical Cannabis Industry and are personally involved in every ongoing project, as well as the planning of future endeavors. Seach evolved to be one of the leading Medical Cannabis growers and suppliers in Israel, breeding, growing and supplying top grade medical Cannabis to Hospitals, Clinical Trials and Patients. We are deeply involved in Cannabis related medical research, clinical trials and development of a wide range of Cannabis oriented technologies in our technology incubator. Seach is a member of the Israeli Cannabis Growers Association, and held the position of Chairman for 2 years.

51 to 200 staff

Origene Seeds

ORIGENE SEEDS is an innovative international seed company, active in research, plant breeding, seed production and processing, sales & marketing of hybrid vegetable varieties. The company's strategy is to develop new hybrids with novel traits of quality, taste, flavor, uniformity, high nutrition values, shelf life, all combined with high yield and environmental friendly. The hybrid varieties are suitable for the commercial outdoor crops or greenhouse growers as well for plant raisers, for the professional sectors. Our company breeds vegetables for markets in more than 25 countries.

51 to 200 staff

Profuse Technology

ProFuse is the skeletal muscle growth expert, developing innovative therapies for skeletal muscle loss and products for cultivated meat production. Addressing the critical unmet need for effective drugs for muscle-wasting diseases, ProFuse leverages its proprietary technological assets to efficiently and accurately discover novel muscle therapies. Our platform enables the high-throughput screening of thousands of compounds, identifying promising candidates with a high translational potential. For the cultivated meat industry, we sell cutting-edge products- cell lines and differentiation media supplements to significantly reduce costs, enhance muscle growth, increase yield and accelerate production cycles. ProFuse actively collaborates with leading companies seamlessly integrating our products and knowhow into their production processes. Founded in 2021, ProFuse licensed technology developed over four years of research at the Weizmann Institute of Science. Since then, we have achieved significant milestones, including winning first place in the 2021 Israel FoodTech Startup Competition and securing exclusive grants from both the European Innovation Council and the Israel Innovation Authority. We have launched two product lines and are actively supporting our cultivated meat customers in their scale-up efforts. We are particularly proud of our R&D team's focus on skeletal muscle biology which is strengthened by the expertise of Professors Eldad Tzahor (Weizmann Institute of Science, Israel) and Professor Shulamit Levenberg (Technion, Israel).

11 to 50 staff

Orgenesis Biotech Israel Ltd

Orgenesis Biotech Israel LTD, a subsidiary of Orgenesis Inc, is a specialized process and product development firm focused on custom-made process development, upscaling design from lab to industry innovation and automation procedures, which are extremely essential in the cell therapy industry. The company is located in Bar-Lev Industrial Park utilizing the exclusive Israeli innovative ecosystem and highly experienced and talented associates including Ph.D. holders and Biotechnology engineers. The center provides end to end solutions to cell therapy industries, process development capabilities and proficiency, custom-made engineering, and a unique platform for creative design and process optimization. The company spreads over 1300 sqm2 of labs and offices resulting in an efficient and unique environment for cell therapy development.

11 to 50 staff

A2s Technologies Ltd

A2S technologies Ltd is a trading Biotech supplier company distributing in Israel leading biotech manufacturer. we are specialized in laboratory equipment, with over 15 years experience in the field. We supply products and services to the Biotech, Biopharma, Pharmaceutical, Research institutes, universities and Hospitals. With our "Consulting & Sales" and "Technical Service", we are able to respond to your requests and needs the most accurate when it comes to laboratory equipment. Our collaboration closely linked with our suppliers allows us to be aware at every moment for news and technical specialties. Flexibility is our strength! We offer personalized services tailored to your needs. Try us! Do not hesitate to contact us for any new project planning, equipment or consumables, we seek the best solution and submit you a free quote without obligation on your part.

1 to 10 staff

Huminn

Huminn Convergence Innovation™ operates on the principle that nature is an interdependent and complex system in order to benefit the entire network and not just its separate domains Convergence Innovation™ Uniquely integrated Platform: Huminn is an innovations company at the forefront of science and technology. Working with leading, interdisciplinary scientists, Huminn deploys cutting-edge precision molecular biology tools with proprietary and novel statistical rediction algorithms to create and commercialize visionary integrated solutions to critical global challenges in health, wellness and sustainable development Huminn connects dots - Others compartmentalize. Huminn connects dots. Others see problems. Huminn marries new tech, new thinking, and a new cast of collaborators to create sustainable solutions that have signicant positive economic, environmental and cultural impact

11 to 50 staff

Neotx Therapeutics Ltd

NeoTX is a specialty biopharmaceutical company, with a focus on research and development in oncology immunotherapy. With a strong research and development team, our strategy is to build a patented, proprietary and unique product pipeline to capitalize on technologies that NeoTX is developing independently and through collaborative partnerships and license agreements.

11 to 50 staff

Sequentify

At Sequentify, we empower genomic labs to achieve scalable, population-wide genomic sequencing through our innovative solutions. Our technology is designed to decentralize genomic testing by addressing the industry's top three challenges: sample preparation, result analysis, and cost reduction. Our end-to-end solution offers unmatched scalability, automation friendliness, and cost-effectiveness, making it ideal for diverse applications, including cancer diagnostics, carrier screening, and infectious disease. Currently raising our Series A round, as we aim to accelerate growth.

11 to 50 staff

Biological Industries Sartorius

BIOLOGICAL INDUSTRIES (BI) develops, manufactures and supplies life science products to universities, government research and healthcare institutions and to the bio-pharmaceutical industry. With an in-house R&D Department and over 30 years of experience, as well as through know-how collaborations with academic researchers, we have introduced a series of serum-free media and many other products for animal tissue culture and molecular biology. In recent years, we have developed NutriStem®- a serum-free, xeno-free gold standard media advancing the fields of stem cell-based therapies. BI manufactures in a cGMP compliant facility that consists of ISO 5, 7 and 8 clean rooms, and holds ISO 13485:2003 and ISO 9001:2008 certifications. We are committed to a Culture of Excellence through high quality, cost-effective and innovative products and services, tailored to our customer's specific needs. Locations include the USA, Europe, China and Israel.

51 to 200 staff

Imbh - For Life Science

Proven products. Reliable service. Expert consultation. For decades, researchers have relied on our media, cell cultures, reagents, and kits for their laboratories. Our proven products and equipment are sourced from leading companies for use in cell culture & analysis, protein analysis, and more. Working closely with our customers, our handpicked team devises custom solutions for cell authentication and cell bank production and specialized kits and reagents to help researchers achieve the results they want.

11 to 50 staff

Longevity Ai

Transform your practice's clinical and lifestyle data into personalized, evidence based longevity plans - automatically.

11 to 50 staff

Nibn The National Institute For Biotechnology In The Negev

The National Institute for Biotechnology in the Negev Ltd. is a research Institute that serves as an accelerator for technologies originating from Ben-Gurion University of the Negev, and located in the University campus. The institute's goal is to promote applied, innovative and groundbreaking research in the field of biotechnology, while leading the proof of scientific concept and commercialization. The research at the Institute focuses on areas that are at the forefront of the development of the pharma industry: Cancer, Degenerative diseases, Autoimmune and Metabolic diseases, Infectious diseases, Genetic diseases, as well as, applied Biotechnological research in the fields of AgBio. The research at the Institute has yielded over 900 publications in leading scientific journals, more than 60 patent families and a number of commercializations, mainly, licensing breakthrough technologies to third parties for further development and as a basis for establishing new startups.

51 to 200 staff

Plantarcbio

PlantArcBio Ltd.(TASE:PLNT) is an ag-biotech company developing gene discovery and RNAi-based solutions to enhance crop traits and biologically control pests, with a vision to improve global food security and promote sustainable agriculture. With our patented DIP™ and DIPPER™ technologies, we discover and develop novel genes and gene-editing targets, as well as support gene editing processes, with game-changing effects on plants — including yield improvement, drought resistance, herbicide tolerance, and nutritional enhancement. Genes identified through the DIP™ platform enable seed companies to enhance a variety of crops with desired traits more effectively than ever before. For example, PlantArcBio partnered with seed company Rallis to develop drought-tolerant corn, demonstrating a 60%–250% yield increase under drought conditions. Our DIP™ and DIPPER™ platforms, along with the novel genes and RNAi targets we have discovered and developed, are protected by patents at various stages of registration. We have signed multiple partnerships with leading seed and crop protection companies to enhance crops with drought resistance, increased yield, herbicide tolerance, and insect resistance. We are seeking additional partners to introduce our novel genetic technologies and further improve crop performance. Our RNAi developments focus on external applications and integrated solutions for crop protection and yield enhancement. Our deep expertise and innovative RNAi technologies, combined with a unique methodology for identifying target gene sequences, make us a strong partner for co-developing next-generation RNAi pest control solutions. PlantArcBio's global strategic partners include ICL, Gadot-Agro, KWS, CTC (Brazil), TMG (Brazil), Bioceres (Argentina), Rallis (a subsidiary of TATA, India), Toolgen (Korea) and others.

11 to 50 staff

Scivac Limited

SciVac Ltd, a subsidiary of VBI Vaccines Inc.(Nasdaq: VBIV), has the facilities and expertise that enable development of therapeutic proteins starting with a selected clone, through production, purification, and analytical testing. For your phase I and II clinical trials, SciVac Ltd. offers manufacturing services under cGMP conditions.

11 to 50 staff

Hallura

Breaking with 20-year-old technologies and answering the growing demand for natural and soft aesthetic treatments, HALLURA is reinventing Hyaluronic Acid Dermal Fillers

1 to 10 staff

Ela Pharma Ltd

Ela Pharma is driven to create novel therapeutics for better patient recovery and care, in the most pressing clinical applications such as organ preservation, retinal artery occlusion, acute ischemic conditions and acute liver failure. Our proprietary technology is based on small molecules to inhibit intracellular proteolytic enzymes targeting novel anti-necrotic based pathways.

1 to 10 staff

Liposphere Ltd

Liposphere is a biomedical start-up company spun out from the Weizmann Institute of Science (Israel) in 2019. The Company develops highly lubricious, water-based, biocompatible nanomaterials for conditions of the human body, where ultralow friction is of utmost importance. The team has spent over 10 years on basic academic research and development of the compound at the Weizmann Institute before spinning out the technology. LipOsphere’s technological advantage, based on the discovery of the Hydration Lubrication Mechanism, is worldwide IP protected.

11 to 50 staff

Opko Biologics Ltd

OPKO Biologics Ltd.(formerly Prolor Biotech), a subsidiary of OPKO Health Inc, is a clinical stage company developing next-generation, bio-better, long-acting versions of therapeutic proteins and peptide drugs, utilizing CTP and reversible PEGylation technologies. The CTP technology involves fusing one or more copies of a naturally occurring glycosylated peptide by rDNA technology to the protein chain ends. When attached to a therapeutic protein, CTP significantly extends its longevity in the body. OPKO Biologics’ second technology is reversible PEGylation, a synthetic chemistry-based platform for enhancing the half-life of therapeutic peptides and small molecules. Using a hydrolysable linker bypasses the disadvantages of using a standard PEGylated molecule, i.e. the potential for steric hindrance that limits its function, and the limited ability to cross cellular membranes or the blood-brain barrier. OPKO Biologics currently presents two bio-better long-acting products: hGH-CTP (Somatrogon, MOD-4023): CTP-modified human growth hormone (hGH). OPKO completed a pivotal Phase 3 study in growth hormone-deficient (GHD) adults and is currently conducting a Phase 3 study in a GHD pediatric population. The company completed a Phase 2 study in GHD adults, demonstrating that a single weekly injection of hGH-CTP could potentially substitute seven consecutive daily injections of regular hGH, and showing an excellent safety profile. OPK88005: CTP-modified long-acting coagulation factor VIIa, potentiality supporting every-other-day prophylactic treatment or twice a week regimen in hemophilia patients. OPK88005 is currently evaluated in an ongoing Phase 2a clinical study.

51 to 200 staff

Lifegene - People Connecting Science

At LifeGene we believe in making the difference, we are an eco-friendly company with a dynamic style and a creative approach. We are committed to focusing on the needs of our customers and to providing service of the highest quality. Our aim is to be a part of our customers' success and to follow them and support them in their breakthroughs in life science research.

1 to 10 staff

Transalgae

Microalgae based oral delivery platform

11 to 50 staff

Caleetech

CaleeTech is a biotech startup specializing in providing novel solutions for obesity and diabetes (diabesity). CaleeTech will improve diabetic parameters and weight management by significantly reducing calory absorption, blood sugar, and fat level without compromising on the patient's quality of life. CaleeTech product is unique, has a high safety profile, is transient and can be used repeatedly. It also addresses market trends – as a quick solution, easy to use, based on natural ingredients and affordable. It was extensively tested on bench and in-vivo with successful recovery and histopathological studies. A clear regulatory strategy is in place after productive meetings with the FDA, and Phase 1 successful clinical trial performed in 2023 in a RAMBAM, diabetes department.

1 to 10 staff